[Treatment of toxic hepatitis in COVID-19 patients].

Maev, I V; Shaburov, R I; Pavlov, A I; Molodova, A I; Karakozov, A G; Kazakov, S P; Lebedeva, E G; Ivolgin, A F; Eremin, M N; Levchenko, O B

Maev, I V; Shaburov, R I; Pavlov, A I; Molodova, A I; Karakozov, A G; Kazakov, S P; Lebedeva, E G; Ivolgin, A F; Eremin, M N; Levchenko, O B.

Affiliation

Maev IV; Yevdokimov Moscow State University of Medicine and Dentistry.
Shaburov RI; Yevdokimov Moscow State University of Medicine and Dentistry.
Pavlov AI; Central Clinical Hospital "RZhD-Medicine".
Molodova AI; Vishnevsky 3-rd Central Military Clinical Hospital.
Karakozov AG; Yevdokimov Moscow State University of Medicine and Dentistry.
Kazakov SP; Yevdokimov Moscow State University of Medicine and Dentistry.
Lebedeva EG; Russian Medical Academy of Continuous Professional Education.
Ivolgin AF; Burdenko Main Military Clinical Hospital.
Eremin MN; Yevdokimov Moscow State University of Medicine and Dentistry.
Levchenko OB; Vishnevsky 3-rd Central Military Clinical Hospital.

Ter Arkh ; 94(12): 1413-1420, 2023 Jan 16.

Article de Ru | MEDLINE | ID: mdl-37167187

Sujet(s)
Mots clés

COVID-19; combination therapy; diagnosis; hepatoprotective; laboratory parameters; monotherapy; predictor; toxic hepatitis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lésions hépatiques dues aux substances / COVID-19 / Ictère Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limites: Humans Langue: Ru Journal: Ter Arkh Année: 2023 Type de document: Article Pays de publication: Russie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google